Annual Total Expenses
$226.62 M
+$54.00 M+31.28%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual total expenses is currently $226.62 million, with the most recent change of +$54.00 million (+31.28%) on 31 December 2023. During the last 3 years, it has risen by +$151.67 million (+202.35%). CRNX annual total expenses is now at all-time high.CRNX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$87.80 M
+$4.62 M+5.55%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly total expenses is currently $87.80 million, with the most recent change of +$4.62 million (+5.55%) on 30 September 2024. Over the past year, it has increased by +$28.47 million (+48.00%). CRNX quarterly total expenses is now at all-time high.CRNX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +31.3% | +48.0% |
3 y3 years | +202.3% | +215.7% |
5 y5 years | +689.4% | +476.5% |
CRNX Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +202.3% | at high | +215.7% |
5 y | 5 years | at high | +689.4% | at high | +477.1% |
alltime | all time | at high | +3649.5% | at high | +5243.7% |
Crinetics Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $87.80 M(+5.5%) |
June 2024 | - | $83.18 M(+12.2%) |
Mar 2024 | - | $74.17 M(+18.4%) |
Dec 2023 | $226.62 M(+31.3%) | $62.66 M(+5.6%) |
Sept 2023 | - | $59.32 M(+9.9%) |
June 2023 | - | $53.98 M(+6.6%) |
Mar 2023 | - | $50.66 M(+5.0%) |
Dec 2022 | $172.62 M(+58.7%) | $48.27 M(+9.9%) |
Sept 2022 | - | $43.91 M(+1.0%) |
June 2022 | - | $43.48 M(+17.7%) |
Mar 2022 | - | $36.96 M(+15.6%) |
Dec 2021 | $108.78 M(+45.1%) | $31.97 M(+15.0%) |
Sept 2021 | - | $27.81 M(+6.6%) |
June 2021 | - | $26.09 M(+13.8%) |
Mar 2021 | - | $22.92 M(+5.2%) |
Dec 2020 | $74.95 M | $21.79 M(+18.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $18.45 M(+9.0%) |
June 2020 | - | $16.93 M(-4.8%) |
Mar 2020 | - | $17.78 M(+16.9%) |
Dec 2019 | $53.83 M(+87.5%) | $15.21 M(-0.1%) |
Sept 2019 | - | $15.23 M(+14.1%) |
June 2019 | - | $13.35 M(+32.9%) |
Mar 2019 | - | $10.04 M(+6.5%) |
Dec 2018 | $28.71 M(+214.6%) | $9.43 M(+16.9%) |
Sept 2018 | - | $8.07 M(+42.0%) |
June 2018 | - | $5.68 M(+2.8%) |
Mar 2018 | - | $5.53 M(+121.0%) |
Dec 2017 | $9.13 M(+51.0%) | $2.50 M(+5.3%) |
Sept 2017 | - | $2.37 M(+44.5%) |
June 2017 | - | $1.64 M(-37.0%) |
Mar 2017 | - | $2.61 M |
Dec 2016 | $6.04 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual total expenses year-on-year change?
- What is Crinetics Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly total expenses year-on-year change?
What is Crinetics Pharmaceuticals annual total expenses?
The current annual total expenses of CRNX is $226.62 M
What is the all time high annual total expenses for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual total expenses is $226.62 M
What is Crinetics Pharmaceuticals annual total expenses year-on-year change?
Over the past year, CRNX annual total expenses has changed by +$54.00 M (+31.28%)
What is Crinetics Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of CRNX is $87.80 M
What is the all time high quarterly total expenses for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly total expenses is $87.80 M
What is Crinetics Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, CRNX quarterly total expenses has changed by +$28.47 M (+48.00%)